{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:27:05Z","timestamp":1787840825228,"version":"build-2784847793"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Grant Agency of the Charles University","award":["GAUK 132010"],"award-info":[{"award-number":["GAUK 132010"]}]},{"name":"Czech Ministries of Education and Health","award":["PRVOUK-P26\/LF1\/4"],"award-info":[{"award-number":["PRVOUK-P26\/LF1\/4"]}]},{"name":"Czech Ministries of Education and Health","award":["NT13237-4\/2012"],"award-info":[{"award-number":["NT13237-4\/2012"]}]},{"name":"National Health Service National Specialised Commissioning Group for Neuromyelitis Optica"},{"name":"National Institute for Health Research Oxford Biomedical Research Centre"},{"name":"Swiss National Foundation","award":["310030_134900\/1"],"award-info":[{"award-number":["310030_134900\/1"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jneuroim.2014.07.001","type":"journal-article","created":{"date-parts":[[2014,7,11]],"date-time":"2014-07-11T05:02:31Z","timestamp":1405054951000},"page":"185-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Complement activation in patients with neuromyelitis optica"],"prefix":"10.1016","volume":"274","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4885-602X","authenticated-orcid":false,"given":"Petra","family":"Nytrova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliska","family":"Potlukova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1398-5796","authenticated-orcid":false,"given":"David","family":"Kemlink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Woodhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3054-065X","authenticated-orcid":false,"given":"Dana","family":"Horakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Havrdova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Zivorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marten","family":"Trendelenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2014.07.001_bb0005","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/jnen\/64.2.147","article-title":"The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions","volume":"64","author":"Brink","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0010","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/(SICI)1098-1136(199905)26:3<201::AID-GLIA2>3.0.CO;2-M","article-title":"Receptor for the C3a anaphylatoxin is expressed by neurons and glial cells","volume":"26","author":"Davoust","year":"1999","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0015","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1212\/01.WNL.0000289761.64862.ce","article-title":"Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica","volume":"69","author":"Hinson","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0020","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1046\/j.1471-4159.1998.71062487.x","article-title":"Expression of a functional anaphylatoxin C3a receptor by astrocytes","volume":"71","author":"Ischenko","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0025","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncpneuro0764","article-title":"Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica","volume":"4","author":"Jarius","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-5793(03)00060-7","article-title":"Complement component anaphylatoxins upregulate chemokine expression by human astrocytes","volume":"537","author":"Jauneau","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0035","doi-asserted-by":"crossref","first-page":"11274","DOI":"10.1021\/bi00161a003","article-title":"C3a receptor on dibutyryl-cAMP-differentiated U937 cells and human neutrophils: the human C3a receptor characterized by functional responses and 125I-C3a binding","volume":"31","author":"Klos","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0040","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jneuroim.2012.09.002","article-title":"Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica","volume":"254","author":"Kuroda","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0045","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0050","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0055","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0060","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos","year":"2012","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0065","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00401-013-1128-3","article-title":"C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica","volume":"125","author":"Phuan","year":"2013","journal-title":"Acta. Neuropathol."},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0065-2776(01)76021-X","article-title":"Systemic lupus erythematosus, complement deficiency, and apoptosis","volume":"76","author":"Pickering","year":"2000","journal-title":"Advances in immunology"},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0075","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S1474-4422(13)70076-0","article-title":"Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study","volume":"12","author":"Pittock","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0080","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0085","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-3083.2008.02089.x","article-title":"Complement component c1q and anti-c1q antibodies in theory and in clinical practice","volume":"67","author":"Potlukova","year":"2008","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0090","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0095","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","volume":"133","author":"Saadoun","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0100","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1046\/j.1471-4159.1999.0722426.x","article-title":"Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression","volume":"72","author":"Sayah","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0105","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0022-510X(98)00086-0","article-title":"Intrathecal activation of the complement system and disability in multiple sclerosis","volume":"157","author":"Sellebjerg","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1046\/j.1365-2249.1999.00867.x","article-title":"Autoantibodies against C1q: view on clinical relevance and pathogenic role","volume":"116","author":"Siegert","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0115","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00281-005-0007-y","article-title":"Antibodies against C1q in patients with systemic lupus erythematosus","volume":"27","author":"Trendelenburg","year":"2005","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0120","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1093\/ndt\/gfl436","article-title":"High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis","volume":"21","author":"Trendelenburg","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0125","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jneuroim.2010.11.010","article-title":"Enhanced complement consumption in neuromyelitis optica and Behcet's disease patients","volume":"233","author":"Tuzun","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0130","doi-asserted-by":"crossref","first-page":"18697","DOI":"10.1073\/pnas.0607283103","article-title":"Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptors","volume":"103","author":"Urich","year":"2006","journal-title":"Proc. Natl. Acad. SciU S A"},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0135","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cca.2013.03.020","article-title":"Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks","volume":"421","author":"Uzawa","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0140","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00001756-200102120-00022","article-title":"Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death","volume":"12","author":"van Beek","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0145","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.molimm.2013.09.010","article-title":"A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission","volume":"57","author":"Veszeli","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0150","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.65.7.913","article-title":"Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis","volume":"65","author":"Waters","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0155","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","article-title":"Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays","volume":"78","author":"Waters","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0160","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1006\/clim.2001.5125","article-title":"Evidence of a role for C4 in modulating interstitial inflammation in experimental glomerulonephritis","volume":"101","author":"Welch","year":"2001","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0165","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.nrl.0000250927.21903.f8","article-title":"Diagnosis and treatment of neuromyelitis optica","volume":"13","author":"Wingerchuk","year":"2007","journal-title":"Neurologist"},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0170","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0175","first-page":"884","article-title":"IgG autoantibody to the collagen-like region of Clq in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus, and 6 other musculoskeletal or rheumatic diseases","volume":"19","author":"Wisnieski","year":"1992","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jneuroim.2014.07.001_bb0180","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.intimp.2011.11.006","article-title":"Inhibitory effects of C4a on chemoattractant and secretagogue functions of the other anaphylatoxins via Gi protein-adenylyl cyclase inhibition pathway in mast cells","volume":"12","author":"Xie","year":"2012","journal-title":"Int. Immunopharmacol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572814002161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572814002161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:22:33Z","timestamp":1759047753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572814002161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0165572814002161"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2014.07.001","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement activation in patients with neuromyelitis optica","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2014.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}